Effect of prior chemotherapy on survival in patients from the randomized phase III J-ALEX study of alectinib versus crizotinib in ALK -positive non-small cell lung cancer

JAAD International · Elsevier

Аннотация

Publication date: September 2026 Source: International Journal of Lung Cancer, Volume 1, Issue 3 Author(s): Tetsuya Mitsudomi, Makoto Nishio, Kazuhiko Nakagawa, Nobuyuki Yamamoto, Shinji Takeuchi, Ryohei Katayama, Hiroyuki Sakaguchi, Miki Nomura, Takuya Yoshimoto, Tomohide Tamura

Читать у издателя →

Похожие статьи